ACT-451840
ACT-451840 is an orally active, potent, and low-toxicity antimalarial research compound with an artemisinin-like mechanism. It demonstrates rapid action against all asexual blood stages of both sensitive and resistant P. falciparum, showing 99.80% parasite reduction in vivo at 30 mg/kg. This profile supports its investigation for malaria drug discovery and resistance studies.
Product Specifications
CAS Number
1984890-99-4
Product Name Alternative
ACT451840
Field of Research
Infectious Disease & Virology
Purity
96.07% (May vary between batches)
Solubility
DMSO:30 mg/mL (39.95 mM)
Smiles
CC (=O) N1CCN (CC1) c1ccc (CN ([C@@H] (Cc2ccccc2) C (=O) N2CCN (Cc3ccc (cc3) C#N) CC2) C (=O) \C=C\c2ccc (cc2) C (C) (C) C) cc1
Molecular Formula
C47H54N6O3
Molecular Weight
750.97
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
EK341911 96 Well
Human TWEAK (Tumour Necrosis Factor Related Weak Inducer of Apoptosis) ValidElisa Kit
Sign In for Pricing
View Details 
M00229-1-Dylight488 100 µg
Anti-Tuberin TSC2 Antibody Picoband® (monoclonal, 6I3) (Dylight488 Conjugate)
Sign In for Pricing
View Details